• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu

Bivalent chromatin as a therapeutic target in cancer: An in silico predictive approach for combining epigenetic drugs

21 de June de 2021
PLoS Comput Biol. 2021 Jun 21;17(6):e1008408. doi: 10.1371/journal.pcbi.1008408.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-06-21 10:00:002021-06-21 10:00:00Bivalent chromatin as a therapeutic target in cancer: An in silico predictive approach for combining epigenetic drugs

Glutaminolysis-induced mTORC1 activation drives non-alcoholic steatohepatitis progression

7 de May de 2021
J Hepatol. 2021 May 4:S0168-8278(21)00302-0. doi: 10.1016/j.jhep.2021.04.037.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-05-07 10:00:002021-05-07 10:00:00Glutaminolysis-induced mTORC1 activation drives non-alcoholic steatohepatitis progression

Coupling Machine Learning and Lipidomics as a Tool to Investigate Metabolic Dysfunction-Associated Fatty Liver Disease. A General Overview

3 de April de 2021
Biomolecules. 2021 Mar 22;11(3):473. doi: 10.3390/biom11030473.ABSTRACTHepatic…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-04-03 10:00:002021-04-03 10:00:00Coupling Machine Learning and Lipidomics as a Tool to Investigate Metabolic Dysfunction-Associated Fatty Liver Disease. A General Overview

Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer

3 de April de 2021
Cancers (Basel). 2021 Mar 6;13(5):1132. doi: 10.3390/cancers13051132.ABSTRACTThe…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-04-03 10:00:002021-04-03 10:00:00Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer

The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer

27 de March de 2021
Nat Commun. 2021 Mar 26;12(1):1920. doi: 10.1038/s41467-021-22101-7.ABSTRACTAdipogenesis…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-03-27 10:00:002021-03-27 10:00:00The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer

Synaptic plasticity as Bayesian inference

12 de March de 2021
Nat Neurosci. 2021 Apr;24(4):565-571. doi: 10.1038/s41593-021-00809-5.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-03-12 11:00:002021-03-12 11:00:00Synaptic plasticity as Bayesian inference

Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology

19 de February de 2021
Front Oncol. 2021 Feb 2;10:620641. doi: 10.3389/fonc.2020.620641.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-02-19 11:00:002021-02-19 11:00:00Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology

Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer

18 de December de 2020
Aging (Albany NY). 2020 Dec 10;12(24):24671-24692. doi: 10.18632/aging.202289.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2020-12-18 11:00:002020-12-18 11:00:00Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer

Mimetics of extra virgin olive oil phenols with anti-cancer stem cell activity

10 de November de 2020
Aging (Albany NY). 2020 Nov 9;12(21):21057-21075. doi: 10.18632/aging.202154.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2020-11-10 11:00:002020-11-10 11:00:00Mimetics of extra virgin olive oil phenols with anti-cancer stem cell activity

Systemic overexpression of C-C motif chemokine ligand 2 promotes metabolic dysregulation and premature death in mice with accelerated aging

26 de October de 2020
Aging (Albany NY). 2020 Oct 26;12(20):20001-20023. doi: 10.18632/aging.104154.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2020-10-26 10:00:002020-10-26 10:00:00Systemic overexpression of C-C motif chemokine ligand 2 promotes metabolic dysregulation and premature death in mice with accelerated aging

Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer

22 de October de 2020
Int J Mol Sci. 2020 Oct 19;21(20):7737. doi: 10.3390/ijms21207737.ABSTRACTSustained…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2020-10-22 10:00:002020-10-22 10:00:00Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer

Fatty Acid Synthase Is a Key Enabler for Endocrine Resistance in Heregulin-Overexpressing Luminal B-Like Breast Cancer

21 de October de 2020
Int J Mol Sci. 2020 Oct 16;21(20):7661. doi: 10.3390/ijms21207661.ABSTRACTHER2…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2020-10-21 10:00:002020-10-21 10:00:00Fatty Acid Synthase Is a Key Enabler for Endocrine Resistance in Heregulin-Overexpressing Luminal B-Like Breast Cancer
Page 5 of 11«‹34567›»

Filter by categories

  • Alemany’s & Piulats’s lab (131)
  • Antolin's lab (36)
  • Aytes's Lab (24)
  • Belver's Lab (25)
  • Casanovas's Lab (77)
  • Martínez-Balibrea's Lab (43)
  • Menendez's Lab (121)
  • Molleví's Lab (35)
  • Pujana's Lab (110)
  • Sureda's & Farre's Lab (259)
  • Viñals's lab (111)

Twitter

Tweets by ProcureICO
Program Against Cancer Therapeutic Resistance

CONTACT US

Campus IDIBELL
(L’Hospitalet del Llobregat)
Hospital Duran i Reynals, Gran Via 199,
L’Hospitalet del Llobregat,
Barcelona 08908
Tel. +34 93 260 7952

Campus IGTP-IJC
(Badalona)
Campus Can Ruti – IGTP – Building Muntanya,
Rd. Can Ruti, Camí de les escoles s/n,
Badalona, Barcelona 08916
Tel. +34 93 554 3069

Campus IDIBGI
(Girona)
Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
Salt, Girona 17190
Tel. +34 872 987 087

© Copyright - Edisenius
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
Scroll to top
Manage cookie consent
To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}